Anuh Pharma Ltd
Anuh Pharma Ltd Share Price Today: Live Updates & Key Insights
Get insights on Anuh Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Anuh Pharma Ltd Share Price Chart
Anuh Pharma Ltd Fundamentals
Traded Volume: 31,035
Market Cap(Cr): 797
Avg Traded Price 79.82
1 Year return %
Upper Circuit 81.3
Lower Circuit 79.1
P/E TTM 21.00
P/B Ratio 4.00
Traded Value(Cr) 24.69
EPS TTM 3.863
Book value 3.863
Dividend 2.00%
Anuh Pharma Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Anuh Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Anuh Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -3.26%
1M -1.02%
3M -12.91%
1Y null%
YTD -30.53%
Anuh Pharma Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Anuh Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 14822.00
Day Before Yesterday 31918.00
1W Avg 30807.60
1M Avg 79114.57
3M Avg 57698.19
Anuh Pharma Ltd Technical Details
Anuh Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 79
Support 2 79
Support 3 79
Pivot Point : 80
Resistance 1 80
Resistance 2 81
Resistance 3 81
Anuh Pharma Ltd Corporate Actions
Anuh Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Anuh Pharma Ltd’s capital allocation strategies.
All
Ex-Date 14-Aug-2025 Type D Description 1.50/share@30.00% Record Date 15-Aug-2025 Ratio 30.00
Ex-Date 15-Jul-2025 Type B Description share@1:1 Record Date 15-Jul-2025 Ratio 1:1
Ex-Date 16-Aug-2024 Type D Description 2.50/share@50.00% Record Date 16-Aug-2024 Ratio 50.00
Ex-Date 11-Aug-2023 Type D Description 2.00/share@40.00% Record Date 11-Aug-2023 Ratio 40.00
Ex-Date 03-Aug-2022 Type D Description 1.75/share@35.00% Record Date - Ratio 35.00
Ex-Date 17-Aug-2021 Type D Description 1.50/share@30.00% Record Date - Ratio 30.00
Ex-Date 18-Sep-2020 Type B Description share@1:1 Record Date 21-Sep-2020 Ratio 1:1
Ex-Date 05-Mar-2020 Type D Description 2.75/share@55.00% Record Date 06-Mar-2020 Ratio 55.00
Ex-Date 14-Aug-2019 Type D Description 2.75/share@55.00% Record Date - Ratio 55.00
Ex-Date 27-Jul-2018 Type D Description 2.75/share@55.00% Record Date - Ratio 55.00
Ex-Date 15-Sep-2017 Type D Description 2.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 15-Sep-2016 Type D Description 0.50/share@10.00% Record Date - Ratio 10.00
Ex-Date 22-Mar-2016 Type D Description 2.00/share@40.00% Record Date 23-Mar-2016 Ratio 40.00
Ex-Date 05-Aug-2015 Type B Description share@2:1 Record Date 06-Aug-2015 Ratio 2:1
Ex-Date 01-Jul-2015 Type D Description 5.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 04-Sep-2014 Type D Description 6.50/share@130.00% Record Date - Ratio 130.00
Ex-Date 04-Sep-2014 Type D Description 2.00/share@40.00% Record Date - Ratio 40.00
Ex-Date 07-Mar-2014 Type D Description 1.25/share@25.00% Record Date 10-Mar-2014 Ratio 25.00
Ex-Date 25-Jul-2013 Type D Description 6.00/share@120.00% Record Date - Ratio 120.00
Ex-Date 16-Aug-2012 Type D Description 5.50/share@110.00% Record Date - Ratio 110.00
Ex-Date 21-Sep-2011 Type D Description 5.00/share@100.00% Record Date - Ratio 100.00
Ex-Date 28-Oct-2010 Type B Description share@2:1 Record Date 29-Oct-2010 Ratio 2:1
Ex-Date 22-Feb-2010 Type D Description 10.00/share@200.00% Record Date 23-Feb-2010 Ratio 200.00
Ex-Date 09-Sep-2009 Type D Description 2.50/share@50.00% Record Date - Ratio 50.00
Ex-Date 09-Sep-2009 Type D Description 9.00/share@180.00% Record Date - Ratio 180.00
Ex-Date 04-Sep-2008 Type D Description 8.00/share@160.00% Record Date - Ratio 160.00
Ex-Date 22-Mar-2007 Type D Description 7.00/share@140.00% Record Date 23-Mar-2007 Ratio 140.00
Dividends
Announcement Date 14-Aug-2025 Ex Dividend Date 14-Aug-2025 Dividend(%) 30
Announcement Date 16-Aug-2024 Ex Dividend Date 16-Aug-2024 Dividend(%) 50
Announcement Date 11-Aug-2023 Ex Dividend Date 11-Aug-2023 Dividend(%) 40
Announcement Date 03-Aug-2022 Ex Dividend Date 03-Aug-2022 Dividend(%) 35
Announcement Date 17-Aug-2021 Ex Dividend Date 17-Aug-2021 Dividend(%) 30
Announcement Date 05-Mar-2020 Ex Dividend Date 05-Mar-2020 Dividend(%) 55
Announcement Date 14-Aug-2019 Ex Dividend Date 14-Aug-2019 Dividend(%) 55
Announcement Date 27-Jul-2018 Ex Dividend Date 27-Jul-2018 Dividend(%) 55
Announcement Date 15-Sep-2017 Ex Dividend Date 15-Sep-2017 Dividend(%) 50
Announcement Date 15-Sep-2016 Ex Dividend Date 15-Sep-2016 Dividend(%) 10
Announcement Date 22-Mar-2016 Ex Dividend Date 22-Mar-2016 Dividend(%) 40
Announcement Date 01-Jul-2015 Ex Dividend Date 01-Jul-2015 Dividend(%) 100
Announcement Date 04-Sep-2014 Ex Dividend Date 04-Sep-2014 Dividend(%) 130
Announcement Date 04-Sep-2014 Ex Dividend Date 04-Sep-2014 Dividend(%) 40
Announcement Date 07-Mar-2014 Ex Dividend Date 07-Mar-2014 Dividend(%) 25
Announcement Date 25-Jul-2013 Ex Dividend Date 25-Jul-2013 Dividend(%) 120
Announcement Date 16-Aug-2012 Ex Dividend Date 16-Aug-2012 Dividend(%) 110
Announcement Date 21-Sep-2011 Ex Dividend Date 21-Sep-2011 Dividend(%) 100
Announcement Date 22-Feb-2010 Ex Dividend Date 22-Feb-2010 Dividend(%) 200
Announcement Date 09-Sep-2009 Ex Dividend Date 09-Sep-2009 Dividend(%) 50
Announcement Date 09-Sep-2009 Ex Dividend Date 09-Sep-2009 Dividend(%) 180
Announcement Date 04-Sep-2008 Ex Dividend Date 04-Sep-2008 Dividend(%) 160
Announcement Date 22-Mar-2007 Ex Dividend Date 22-Mar-2007 Dividend(%) 140
Bonus
Record Date 15-Jul-2025 Ex-Bonus Date 15-Jul-2025 Ratio 1:1
Record Date 21-Sep-2020 Ex-Bonus Date 18-Sep-2020 Ratio 1:1
Record Date 06-Aug-2015 Ex-Bonus Date 05-Aug-2015 Ratio 2:1
Record Date 29-Oct-2010 Ex-Bonus Date 28-Oct-2010 Ratio 2:1
Splits
No Split has been declared by ANUHPHR
Others
Rights No Rights has been declared by ANUHPHR
Anuh Pharma Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Anuh Pharma Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Anuh Pharma Ltd's relative performance and valuation against major competitors.
Stock Name Fermenta Biotech Ltd ₹277.00 (-0.56%) M. Cap (Cr) 8.15 1 Yr Return (%) -15.25% P/E (TTM) 7.32 PB Ratio 2.83
Stock Name Remus Pharmaceuticals Ltd ₹695.05 (-4.42%) M. Cap (Cr) 8.19 1 Yr Return (%) -40.60% P/E (TTM) 28.17 PB Ratio 3.20
Stock Name Wanbury Ltd ₹229.50 (-0.33%) M. Cap (Cr) 8.01 1 Yr Return (%) +7.52% P/E (TTM) 15.97 PB Ratio 19.59
Stock Name Anuh Pharma Ltd ₹79.57 (-0.85%) M. Cap (Cr) 7.97 1 Yr Return (%) -16.07% P/E (TTM) 20.61 PB Ratio 2.45
Stock Name Bharat Parenterals Ltd ₹1103.35 (-1.13%) M. Cap (Cr) 7.60 1 Yr Return (%) -27.71% P/E (TTM) -140.56 PB Ratio 2.30
Stock Name Accent Microcell Ltd ₹308.20 (-2.88%) M. Cap (Cr) 7.39 1 Yr Return (%) +35.56% P/E (TTM) 22.36 PB Ratio 3.15
Stock Name Kilitch Drugs (India) Ltd ₹368.70 (+1.70%) M. Cap (Cr) 6.45 1 Yr Return (%) +23.09% P/E (TTM) 23.37 PB Ratio 2.56
Anuh Pharma Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Anuh Pharma Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 37.12 Mar 2024 12.93 Mar 2023 53.90 Mar 2022 28.86 Mar 2021 -18.73
PARTICULARS Investing Activities Mar 2025 -19.91 Mar 2024 0.92 Mar 2023 -43.48 Mar 2022 -7.82 Mar 2021 52.20
PARTICULARS Financing Activities Mar 2025 -4.86 Mar 2024 -8.57 Mar 2023 -12.29 Mar 2022 -19.45 Mar 2021 -33.12
PARTICULARS Net Cash Flow Mar 2025 12.36 Mar 2024 5.27 Mar 2023 -1.87 Mar 2022 1.60 Mar 2021 0.35
Anuh Pharma Ltd Shareholding Pattern
This shows the ownership breakdown of Anuh Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 71.82%
Public 28.19%
Other Institutions 0%
FII null%
Mutual Funds null%
About Anuh Pharma Ltd
Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals. It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra.The Company was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs.The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries.During the year 2006-07, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg.During the year 2008-09, the company completed the on-going expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production.In January 2010, the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption.In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption.In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.The erection of a new plant for manufacture of drug intermediates, was completed during the year 2010-11 and it got commissioned towards end of February, 2011. In 2012, it received WHO - PQ for Pyrazinamide & acquired R&D assets in Mahape, Navi Mumbai & got DSIR approval. In 2014, it got approval from COFEPRIS - Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate. In 2015, it received approval of WHO - PQ for Sulfadoxine.In March 2019, the Company opened new expansion with an additional capacity of 900 MTPA for 20 different products. It commissioned the new expansion project by starting commercial production in December, 2019.It received CEP for Ambroxol Hydrochloride from EDQM in 2022. In FY 2023-24, Company enhanced production capacity from 1,500 MTPA to 1,800 MTPA at Boisar site.In FY 2025, Company made strong progress with the launch of six new products, adding 40 new export customers and partnerships, and further strengthening its regulatory foundation. The Company steadily expanded its infrastructure by operating a total of 9 API blocks and 2 intermediate blocks, bringing the total installed capacity to 2,400 metric tons per annum in FY 2025.
Vice Chairman
Bipin N Shah
Registered office 3-A Shivsagar Estate, North Wing Dr A B Road Worli, Mumbai, Maharashtra, 400018
FAX :91-22-6622 7575
Background
Incorporation Year 1960
Face Value ₹5.00
Market Lot 1
FAQs on Anuh Pharma Ltd
How to buy Anuh Pharma Ltd shares on NSE?
To buy Anuh Pharma Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Anuh Pharma Ltd share price today?
The Anuh Pharma Ltd share price on NSE is ₹79.57 today.
What is the market cap of Anuh Pharma Ltd on NSE?
The company has a market capitalization of ₹797.48.
What is the PE & PB ratio of Anuh Pharma Ltd?
PE is 21 and PB is 4.
What is the 52 Week High and Low of Anuh Pharma Ltd shares?
Anuh Pharma Ltd stock price high: ₹122.85 Anuh Pharma Ltd stock price low: ₹74.25.